Businesses

Human health

We are focused on the development and supply of high-value, low-volume niche and complex APIs, with a wide presence across therapies like anti-malarial, anthelmintics, anti-infective, antiviral, CNS and dermatology.

Sequent has invested in facilities with an objective of creating an integrated, flexible unit capable of manufacturing several niche & complex APIs. The manufacturing facalities are capable of meeting the growing demand of our key products in the USFDA and WHO regulated markets.

Alivira Animal Health

Alivira is one of the world's leading producers of Animal Health APIs, and it is gradually emerging as a powerhouse in the global animal health business. The brand is strengthened by best-in-class manufacturing capacities, robust product portfolio, wide market presence and cutting-edge R&D capabilities.

Alivira has state-of-the-art API manufacturing facility at Vizag with a present production of 1,000 MT with scalable capacities. Alivira is set to cater to the growing global API requirements.

Alivira's formulation business has been strengthened by its acquisition in Provet, Turkey. With this we have a formulation facility in Ambernath. We are using in-licensing to strengthen our product portfolio and M&A's to widen our market coverage.

The therapies targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology.

Learn more »

Analytical Solutions

Sequent Research is a leading Contract Research Organization specialized in Analytical and Bio Analytical Services to support the API, Pharmaceutical, Personal Care and Nutraceutical companies.

A GLP compliant facility Certified & approved by ISO 17025, ISO 9001:2008, ISO 14001:2004,TGA, USFDA, WHO.

We provide complete analytical solutions including Method Validation, Stability, Microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeial monographs, customer developed methods or in-house method development.

Learn more »